Medication info
Glafomin SR Tablet 2/500mg

Glafomin SR Tablet 2/500mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201206672 · Approved 2012.08.31

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of antidiabetic agents should be adjusted according to each patient's blood glucose level. Refer to the following for the initial dose, and initiate treatment at the lowest possible dose. 1) When blood glucose is not adequately controlled with existing sulfonylurea or metformin monotherapy: The usual initial dose is 2/500mg per day as glimepiride/metformin hydrochloride. The dose may be adjusted based on the patient's current medications and blood glucose level. If a long-acting sulfonylurea (e.g., chlorpropamide) was used before starting this medication, monitor the patient carefully to prevent hypoglycemia due to excessive pharmacologic effects. 2) When used as a replacement for combination therapy: Administer the same dose as the patient's existing daily doses of glimepiride and metformin hydrochloride. If necessary, the dose may be increased based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: glimepiride 8mg and metformin 2000mg. Appropriate blood glucose monitoring should be performed for this purpose. In general, little additional effect is seen with glimepiride doses above 4mg, although some patients have shown better metabolic control when the dose was increased to 6mg (or 8mg). Administer this medication once daily just before or with breakfast or the main meal. Even if a dose is missed, do not take more than a single dose at the next scheduled administration. This medication is an extended-release formulation; swallow it whole without crushing or chewing (see General Precautions).

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes by using glimepiride and metformin together. It enhances blood sugar management effects when combined with meal and exercise therapy. Therefore, it is effective as an adjunct therapy for patients needing blood sugar control.

How to take

Adult dose

The dose of antidiabetic agents should be adjusted according to each patient's blood glucose level. Refer to the following for the initial dose, and initiate treatment at the lowest possible dose. 1) When blood glucose is not adequately controlled with existing sulfonylurea or metformin monotherapy: The usual initial dose is 2/500mg per day as glimepiride/metformin hydrochloride. The dose may be adjusted based on the patient's current medications and blood glucose level. If a long-acting sulfonylurea (e.g., chlorpropamide) was used before starting this medication, monitor the patient carefully to prevent hypoglycemia due to excessive pharmacologic effects. 2) When used as a replacement for combination therapy: Administer the same dose as the patient's existing daily doses of glimepiride and metformin hydrochloride. If necessary, the dose may be increased based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of each component: glimepiride 8mg and metformin 2000mg. Appropriate blood glucose monitoring should be performed for this purpose. In general, little additional effect is seen with glimepiride doses above 4mg, although some patients have shown better metabolic control when the dose was increased to 6mg (or 8mg). Administer this medication once daily just before or with breakfast or the main meal. Even if a dose is missed, do not take more than a single dose at the next scheduled administration. This medication is an extended-release formulation; swallow it whole without crushing or chewing (see General Precautions).

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, treatment should be stopped and a physician consulted if there is a sudden decrease in kidney function or signs of dehydration. It should not be administered to patients with kidney function below 45 mL/min/1.73m2, and caution is needed when taken with other medications that can affect kidney function in elderly patients. This medication may be associated with increased cardiovascular mortality risk, and the risks and benefits of treatment should be fully understood before taking it. It should not be given to specific patients such as those with type 1 diabetes, acute metabolic acidosis, severe liver function impairment, dialysis patients, congestive heart failure patients, or recent myocardial infarction. During the initial dosing period or in patients at high risk for hypoglycemia (malnutrition, irregular meals, alcohol consumption), special observation for hypoglycemia symptoms is necessary. Gastrointestinal side effects (diarrhea, nausea, etc.) may occur commonly but are usually temporary and can be reduced by taking the medication with meals. If allergic reactions or severe blood abnormalities occur, the physician should be informed immediately, and regular monitoring is necessary due to the risk of vitamin B12 deficiency. This medication should be swallowed whole and not crushed or chewed, and it is normal for the tablet coating to appear in the stool. If hypoglycemia occurs, sugar should be consumed immediately, and in severe cases, medical assistance should be sought. If symptoms of lactic acidosis (fatigue, muscle pain, breathing difficulties, etc.) occur, administration should be stopped immediately, and emergency treatment should be received. Pregnant and nursing women should not take this medication; it is advisable to consult a physician about switching to insulin therapy if blood sugar control is needed. This medication can interact with other drugs, so all currently taken medications should be disclosed to the healthcare provider. In case of overdose, immediate emergency intervention is necessary due to the risk of severe side effects such as hypoglycemia or lactic acidosis. Regular monitoring of blood sugar, kidney function, and hematological tests is required, and any changes in symptoms or condition during treatment should be discussed with a physician. Alcohol consumption may increase the risk of side effects, so it is advisable to avoid it during treatment.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal swelling
  • bloating
  • loss of appetite
  • discomfort
  • metallic taste
Show 62 more
  • visual impairment
  • taste disorder
  • itching
  • urticaria
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • peripheral neuropathy
  • megaloblastic anemia
  • increased liver enzymes
  • liver dysfunction
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency with diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • headache due to hypoglycemia
  • severe hunger
  • weakness
  • drowsiness
  • sleep disturbances
  • instability
  • aggression
  • concentration deficit
  • attention deficit
  • abnormal reactions
  • depression
  • confusion
  • language disorders
  • aphasia
  • tremors
  • paralysis
  • sensory disturbances
  • dizziness
  • inability to self-regulate
  • delirium
  • cerebral seizures
  • loss of consciousness
  • coma
  • weak respiration
  • slow pulse
  • sweating
  • clammy skin
  • rapid pulse
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • upper abdominal pain
  • abdominal discomfort
  • abnormal bowel sounds
  • constipation
  • indigestion
  • hyperkalemia
  • cold

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be kept between 1 degree and 30 degrees Celsius at room temperature. Proper storage will safely maintain the medication's efficacy.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.